Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2754562 | Clinical Lymphoma Myeloma and Leukemia | 2011 | 6 Pages |
Abstract
BackgroundMonoclonal gammopathy of undetermined significance (MGUS) is a plasma cell proliferative disorder that transforms into multiple myeloma and other serious B-cell disorders at an approximate rate of 1% per year; these patients are also at increased risk for fractures.Patients and MethodsWe conducted a retrospective, multicenter study of 100 patients from seven community health clinics to gain a better understanding of the work-up, follow-up, and treatment of these patients.ResultsMGUS patients appear to undergo inadequate work-up, follow-up, and treatment in the community setting.ConclusionsPhysicians should adhere to recently established guidelines to ensure that MGUS patients receive optimal care for this condition.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
James R. Berenson, Ori Yellin, Albert Quiery, James Brady, Ravi Patel, Siu-Fun Wong, Donald Colbourn, Donald Gravenor, Natasha Tiffany, H.K. Shamasunder, Benjamin Waterman, Kathryn Melamed, Eric Wirtschafter,